CAPLIN POINT LABORATORIES LTD. - 524742 - Outcome Of The Board Meeting
Outcome of the Board Meeting04-03-2020
04-03-2020
CAPLIN POINT LABORATORIES LTD. - 524742 - Fixes Record Date for Interim Dividend
Caplin Point Laboratories Ltd has informed BSE that the Company has fixed March 13, 2020 as the Record Date for the purpose of Payment of Interim Dividend.29-02-2020
CAPLIN POINT LABORATORIES LTD. - 524742 - Board Meeting Intimation for Approval Of Interim Dividend For The Financial Year 2019-2020
CAPLIN POINT LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/03/2020 ,inter alia, to consider and approve Interim Dividend for the financial year 2019-202028-02-2020
CAPLIN POINT LABORATORIES LTD. - 524742 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Loss of Share Certificate26-02-2020
Caplin Point Laboratories Ltd - 524742 - Loss of Share Certificate / Issue of Duplicate Share Certificate
Caplin Point Laboratories Ltd has informed BSE regarding Loss of Share Certificate / Issue of Duplicate Share Certificate.21-02-2020
Earnings Call Transcript - Caplin Point Laboratories
Full Earnings Transcript: Conference Call between Management and Analysts18-02-2020
Caplin Point Laboratories Ltd - 524742 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Matthews India Fund14-02-2020
Caplin Point Laboratories Ltd - 524742 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Loss of Share certificate11-02-2020
Caplin Point Laboratories Ltd - 524742 - Clarification
With reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded, Caplin Point Laboratories Ltd has submitted to BSE a copy of Clarification is enclosed.11-02-2020
CAPLIN POINT LABORATORIES LTD. - 524742 - Clarification sought from Caplin Point Laboratories Ltd
The Exchange has sought clarification from Caplin Point Laboratories Ltd on 10th February, 2020 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited.10-02-2020